Although the growth characteristics of Pneumocystis carinii have been described in several cell culture systems, the response of this organism to the drugs of choice, trimethoprim-sulfamethoxazole and pentamidine isethionate, have not been described in vitro. The effect of various concentrations of drugs against P. carinii on the growth of this potentially hazardous opportunistic organism as well as the methodology for in vitro assay of these agents have been detailed. Fluorescence profiles illustrating size ranges of trophozoites and cysts derived from cell culture are described.
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Although the clinical course and treatment of Pneumocystis carinii have been well defined (9, 11) , only limited effort has been devoted to the investigation of the biological and biochemical properties of the organism. Other than the report by Pesanti et al. (18) , no in vitro method has been reported for evaluating existing and potential therapeutic agents against P. carinii. The need for such a system has become increasingly apparent in view of recent reports of trimethoprim-sulfamethoxazole treatment failures (17) and of the increased incidence of P. carinji infections in homosexual males (8) , individuals with acquired immunodeficiency syndrome and their intimate contacts (2) , intravenous drug abusers (15) , infants (3), hemophiliacs (16) , and Haitians (4) . The purpose of the present study, therefore, is to describe in vitro growth characteristics and an in vitro method for evaluation of drugs against P. carinii.
MATERIALS AND METHODS Animals. P. carinii organisms were obtained, by methods previously described in detail (19) , from the lungs of male Sprague-Dawley rats each weighing less than 200 g and treated with cortisone acetate to provoke infection (7) . The animals were sacrificed with sodium pentothal, and the lungs were aseptically removed and shaken vigorously in 25 to 50 ml of cold calcium-and magnesium-free phosphate-buffered saline supplemented with penicillin (500 U/ml), streptomycin (100 Fg/ml), amphotericin B (2.5 ,ug/ml), and gentamicin (50 ,ug/ml).
Inocula for cell culture. The organisms were decanted and centrifuged at 13,200 x g for 15 min in a Sorvall HB4 rotor at 4°C. The pellet was washed repeatedly with cold calcium-and magnesium-free phosphatebuffered saline, suspended in medium 199 (Microbiological Associates, Bethesda, Md.), and cultured for contaminating microorganisms before the addition of antibiotics. The number of P. carinii organisms harvested were quantified by a method involving direct counts of measured volumes of the inocula (19) . Organisms were stained for the purpose of quantitation with toluidine blue 0 (5) and for Cytograf analysis with 10-' M acridine orange.
Cell cultures and growth curves. Embryonic chicken epithelial lung cells were prepared from 14-day-old embryonated eggs by successive treatments with 0.25% pronase by a method designed to eliminate fibroblasts (6) . Primary epithelial cell cultures were grown in 2-ml capacity Leighton tubes containing cover slips (2 by 11 cm) for 24 h before inoculation. The cultures were infected with P. carinii cysts ranging from 7.5 x 103 to 7.5 x 104 cysts per culture, or 3.8 x 103 to 3.8 x 104 cysts per ml. Control cultures were mock infected with normal rat lung washings. The inoculum was allowed to adsorb to the cell monolayers for 2 h, after which time they were supplemented with prewarmed medium 199 in a total volume of 2 ml per culture. Each culture was prepared in triplicate.
At various intervals postinoculation, organisms in the supernatants from Leighton tubes were harvested by centrifugation, suspended in 0.5 ml of medium 199, and counted, as described previously (19) . An For the purpose of drug evaluation, cell cultures were established in Leighton tubes, and each 24-h-old monolayer received 5.4 x 104 cysts. After a 2-h adsorption period at 37°C, during which the organisms were applied to the monolayers in a volume of 0.2 ml of medium, drug-containing medium 199 was added. Control cultures (as described earlier) were mock infected, and equivalent concentrations of drugs were added to the monolayers to test for drug-induced cytopathic effect or toxicity. At the intervals indicated postinoculation, the organisms that were found associated with the cells on Leighton tube cover slips and those in the supernatant were quantified.
Cytographic analysis of P. carinii cysts and trophozoites. The UV absorption of P. carinii organisms in 10-4 M acridine orange was measured on a 100-channel Cytograf analyzer standardized with 2-and 7-,um latex beads. These analyses were conducted on washed organisms from the third cell culture passage. Organisms were suspended in isotonic buffer. To avoid contamination resulting from other cells and microorganisms normally present in rat lungs, only cell culture-grown organisms were used in these studies. Each preparation was stained with toluidine blue 0 and with Giemsa to determine cross-contamination. Each preparation of purified cysts and purified trophozoites contained about 5% trophozoites or cysts, respectively.
P. carinii cysts and trophozoites were separated by low-speed differential centrifugation at room temperature for 8 min at 2,500 rpm (1,800 x g) in phosphatebuffered saline. Trophozoites remained in the supernatant, whereas most of the cysts were in the pellet. Another useful technique involved treating the cyst and trophozoite preparations with sterile, distilled water supplemented overnight with antibiotics. Trophozoite "ghosts" in the supernatant were then removed by low-speed centrifugation that loosely pelleted the cysts.
RESULTS
Growth curves. Growth curves ( Fig. 1 and 2) were plotted by counting a sample of cell-associated cysts and those concentrated by centrifugation from the culture supernatants at time zero and at 24, 48, 120, 144, 168, and 192 h postinoculation. Each value plotted represents the calculated (20) total number of cysts on the cover slips ( Fig. 1 ) or in the supernatants (Fig. 2) Three concentrations of inocula were used to determine the optimal cyst-to-cell ratio for growth of the organisms. It was determined that inocula exceeding 8.5 x 104 cysts per 2.0 x10 primary chicken epithelial lung cells resulted in toxicity and, consequently, a diminished yield of P. carinji organisms. With regard to organisms in inoculum A (7.5 x 104' cysts), during the first 24 h of culture, the number of cysts in the supernatants and those attached to the cell sheet increased rapidly, with the former exhibiting the Cytographc analysis. Cytographic analysis was carnied out with acridine orange stain at 260 nm with two diameters of latex beadsas particle size standards (Fig. 3 and 4) . Purified cysts and trophozoites ( Fig. 5 and 6 ) from cell culture were subjected to analysis, and it was determined that most trophozoites from cell culture fall in the average range of 2 pm in diameter with intermediate sizes, probably representing older trophozoites, in transition to the cyst phase. The cyst preparation peaked in the 7-pm range but also showed the presence of smaller transional forms, as might be expected. These studies were done before biochemical characterization to assess the relative purity of cysts and trophozoites and to obtain a more specific value lon the relative sizes of the two major forms frmn cell culture. As a result of these studies and also on the basis of microscopic examination, it was determined that the trophozoites contained an unacceptable amount of 2-pm-sized debris to yield reliable data for biochemical analysis. cysts, however, were considerably more readily purified and consequently were subjected to preliminary biochemical analysis. In general, cytographic analysis showed that microscopic estimates of fixed and stained cysts and tropho- zoites are essentially accurate with regard to purity.
DISCUSSION
Since the initial report of Pifer et al. (19) , several attempts at cultivation of P. carinii have been described (1, 12, 21) . The need for a reliable means of producing substantial numbers of P. carinii organisms for serological testing is obvious. The noninvasive counterimmunoelectrophoresis test for P. carinii antigenemia relies on these methodologies and appears very promising. This technique uses antibody prepared against cell culture-grown organisms, thus emphasizing the importance of pursuing better methods for cultivating P. carinii (20) . Recently, researchers at the Centers for Disease Control have verified the specificity of-the counterimmunoelectrophoresis test for detecting P. carinji antigenemia and have corroborated the concept presented in 1978 (20) that P. carinji may be present as a subclinical entity in human patients (13, 14) . Immunofluorescence tests for P. carinji antibody in which culture-produced cysts are used appear to be more sensitive, perhaps because organisms grown in culture are not coated with antibody, as are those freshly isolated from lung (20) . The cultivation of P. carinii in vitro, therefore, has found practical application in providing pure and immunologically unreacted organisms for these much-needed adjuncts to the more hazardous invasive methods of diagnosis. At present, it does not appear likely that direct culture without resort to invasive techniques will ever prove useful in confirming P. carinji infection. There is considerable room for improvement, however, in obtaining higher yields from any culture system yet reported.
The cell culture system may prove to be a practical means fot assessing the efficacy of In conclusion, cell culture has provided (i) antibody-free. cysts for use in immunofluorescence assays of antibody to P. carinii, (ii) a source of relatively pure antigen for use in antibody production, thus augmenting the development of specific, noninvasive immunological tests for P. carinii infection, (iii) biological data partially describing the replicative cycle of P. carinii and (iv) a system for evaluating the efficacy of potential drugs to be used in treating P. carinii infections.
